Courses

This continuing education activity will focus on recent clinical trial data as well as therapeutic advances in the increasing role of biosimilars in oncology. The three expert faculty will review the fundamentals of biosimilars in oncology, including bioequivalence, totality of evidence, and interchangeability. A review of current clinical trial data of biosimilars for the treatment of various oncologic therapeutic areas ...
View Course

This continuing education activity will focus on recent clinical trial data and scientific advances in the treatment and management of patients with metastatic colorectal cancer as presented at the 2018 Gastrointestinal Cancers Symposium held in San Francisco, California. Three expert faculty will review the science of colorectal cancer, including patient screening guidelines and molecular characterization. Recent clinical trial data of ...
View Course

This CME program was derived from content presented at the Clinical Congress of Rheumatology 2018 annual meeting in Destin, Florida. The expert faculty, Dr. Grace C. Wright, will discuss the state of disease of rheumatoid arthritis (RA) in an ever evolving treatment landscape. Recent clinical trial data for approved biologic therapies will be analyzed along with data for emerging JAK1/JAK2 ...
View Course

This CME program was derived from content presented at the Clinical Congress of Rheumatology 2018 annual meeting in Destin, Florida. The expert faculty, Drs. Alan L. Epstein and Anthony M. Turkiewicz, will review the pathogenesis of disease as well as joint symptoms for patients with active psoriatic arthritis (PsA). Controversies in the treatment and management of PsA along with rheumatoid ...
View Course

This CME/CNE program will highlight recent advances in the treatment and management of multiple sclerosis (MS) as presented at the 70^th Annual American Academy of Neurology Meeting held in Los Angeles, California. The four expert faculty, led by Dr. Fred Lublin, will review the pathophysiology of MS as well as the mechanisms of action of current therapies. The role of ...
View Course

This CME/CNE program is derived from content presented at the National Lipid Association 2018 Scientific Sessions in Las Vegas, Nevada. The five expert faculty, led by Dr. Alan S. Brown, will review best practices for assessing the risk of cardiovascular disease (CVD). Recently released data, including the results of the ODYSSEY and FOURIER trials, will be outlined followed by a ...
View Course

This CME activity will review optimal treatment strategies and recent clinical trial data for patients with dyslipidemia, as presented at the American College of Cardiology 2018 in Orlando, Florida. Four expert faculty, led by Dr. Christopher Cannon, will analyze the science of LDL cholesterol and how it relates to cardiovascular events. Recent clinical trial data for PCSK9 inhibitors, including data ...
View Course

This CE program will analyze optimal therapeutics for the treatment and management of prostate cancer patients, incorporating data presented at the American Society of Clinical Oncology 2018 Genitourinary (GU) Cancers Symposium in San Francisco, California. The three expert faculty, led by Dr. Elisabeth Heath, will review the framework for clinical decision making in prostate cancer. Recent clinical trial data for ...
View Course

This CME/CE program will delve into the role of oncolytic viral therapy in the treatment and management of the metastatic melanoma patients, highlighting data presented at the Maui and Hawaii Dermatology 2018 annual meetings. The three expert faculty will review the immunotherapy for melanoma, followed by a discussion of recent safety and efficacy trial data for this emerging therapeutic option ...
View Course

This CME/CNE program will highlight recent advances in the treatment and management of breast cancer, as presented at the 40^th Annual San Antonio Breast Cancer Symposium in San Antonio, Texas. Three expert faculty will review the pathophysiology of breast cancer and the rationale for therapeutic choices. An evaluation of recent clinical trial data of current and emerging therapies will be ...
View Course